In contrast, MEF2D was recently identified as a TSG in rhabdomyosarcoma [20] and low-grade uterine leiomyosarcomas [21], thus suggesting that MEF2D plays a cell-type-specific role in cancer cells. Here, MEF2D is linked to rhabdomyosarcoma.